Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

IRRAS Announces Changed Publication Date for the Q1 2022 Interim Report

Stockholm, Sweden (April 25, 2022) – IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that the publication of the company’s interim report for the period from January to March 2022 (“Q1 2022 Interim Report”) will be published on Wednesday, 27 April 2022. Financial calendar for 2022 Report Previously Announced Date New DateQ1 2022 interim report 10 May 2022 27 April 2022Q2 2022 interim report 22 July 2022 UnchangedQ3 2022 interim

Wulff Group Plc’s Interim Report for January 1 – March 31, 2022

This is a summary of Wulff Group Plc’s Interim Report for January-March 2022. Wulff Group’s Interim Report as a whole is attached as a PDF file to this stock exchange release and it is also available on the company’s website www.wulff.fi. The best Q1 in Wulff’s history: net sales increased by 67,2% and operating profit doubled 1.1.-31.3.2022 BRIEFLY · Net sales totalled EUR 25.6 million (15.3), increased by 67.2%. · EBITDA and comparable EBITDA were EUR 1.8 million (0.9). · Operating profit and comparable operating profit (EBIT) amounted to EUR 1.2 million (0.6). ·

Nederman invests in a new manufacturing, logistics and innovation centre in Helsingborg

The environmental technology and industrial air filtration company Nederman, founded in Helsingborg, is developing its operations in Helsingborg by investing in a new manufacturing and logistics facility as well as establishing a global innovation centre.Nederman have production and development expertise, as well as the head office for the Nederman Group and two of its four divisions in Helsingborg. The Nederman Group today employs around 2 200 people whereof 180 are located in Helsingborg. Together with the new manufacturing and logistics unit, the company is establishing the Nederman

Invitation to presentation of LMK Group’s Q1 2022 report

LMK Group will publish its Q1 2022 report on 4 May 2022 at 07:45 CET. In connection with this, LMK Group invites investors, analysts and the media to a conference call and webcast on the same day at 09:00 CET.The presentation will be held in English by CEO Walker Kinman and CFO Erik Bergman and will conclude with a Q&A session. Questions can be asked on the telephone conference call or in written form through the webcast. No preregistration is needed. Date and time4 May 2022 at 09:00 CET Webcasthttps://tv.streamfabriken.com/lmk-group-q1-2022 Phone numberTo participate via

2020 Bulkers Ltd. (2020) – Invitation to webcast and conference call Q1 2022 results

2020 Bulkers Ltd. will release its financial results for the first quarter of 2022 on Wednesday, April 27, 2022. A conference call and webcast will be held at 3:00 PM CET. The earnings report and presentation will be available from the Investor Relations section on www.2020bulkers.com on the same day. In order to listen to the presentation, you may do one of the following: Listen-only webcast (including the slide presentation): https://edge.media-server.com/mmc/p/vhj298wj or you can click the “Webcast” link on www.2020bulkers.com/investor-relations/ Telephone conference Dial in

Tremelimumab US Priority Review for Imfinzi combo

25 April 2022 07:00 BST Tremelimumab accepted under Priority Review in the US for patientswith unresectable liver cancer in combination with Imfinzi STRIDE regimen of a single priming dose of tremelimumab added to Imfinzi is the first dual immune checkpoint blockade regimen to improve overall survival in a Phase III trial in this setting AstraZeneca's Biologics License Application (BLA) for tremelimumab has been accepted for Priority Review in the US, supporting the indication of a single priming dose of the anti-CTLA4 antibody added to Imfinzi (durvalumab) for the treatment of

BioGaia’s result for first quarter to exceed market expectations

(Figures in brackets refer to the same period the previous year) BioGaia´s sales for the first quarter has been positively impacted by an increased demand mainly from the European market. Sales for the first quarter are preliminarily estimated at SEK 284 million (202), up 41%. Operating profit for the first quarter is preliminarily estimated at SEK 95 million (64), up 48%. BioGaia will publish the interim report for the first quarter on Friday, 6 May 2022 at 8:00 a.m., followed by a teleconference at 9:30 a.m. Latest press releases from BioGaia: 05.04.2022 Notice to attend

First day for trading in BoMill’s shares excluding the right to participate in share Issue

The first day of trading in the BoMill share excluding the right to obtain subscription rights is today, April 25, 2022.At the Extraordinary General Meeting on April 8, 2022, it was decided to issue new shares with preferential rights for shareholders in BoMill of approximately SEK 23.3 million. The Rights Issue is secured through underwriting commitments corresponding to 100 percent of the maximum issue volume. Briefly about the Rights Issue · Anyone who on the record date, April 26, 2022, was registered as a shareholder in BoMill has a preferential right to subscribe for shares in

Corem divests two properties in Malmö and Stockholm for SEK 73 million

In two separate transactions, Corem has signed contracts to divest the property Löplinan 7 in Malmö and the site leasehold to the property Mörtö 6 in Stockholm for a total underlying property value of SEK 73 million.The total lettable area amounts to approximately 5,000 sq.m. and primarily consists of office and warehouse premises.Transfer of possession is planned to be on 17 May and 31 May 2022, respectively.Corem Property Group AB (publ)FOR FURTHER INFORMATION, PLEASE CONTACTEva Landén, CEO, +46 8 503 853 33, eva.landen@corem.sePeeter Kinnunen, Head of Transactions, +46 76 855

Africa Energy to Present at Pareto E&P Conference

Vancouver, BC, April 25, 2022 /CNW/ – Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) (“Africa Energy” or the “Company”), an oil and gas company with exploration assets offshore South Africa and Namibia, announces that the Company’s President and Chief Executive Officer, Garrett Soden, will be presenting at the Pareto Securities E&P Independents Conference in London, United Kingdom on Tuesday, April 26, 2022, at approximately 1:40pm British Summer Time. A copy of the presentation will be available on Africa Energy’s website below. Important information The

Etteplan supports Epiroc to develop a battery-electric trolley truck for underground mining

Etteplan Press release April 25, 2022 at 9.00 am EEST  Etteplan is collaborating with Epiroc, a leading mining and infrastructure equipment manufacturer, to enable fossil free underground heavy transportation without interruptions. In a strategic partnership project started in 2021. Etteplan supports Epiroc in redesigning its Minetruck MT42 Battery into an electric trolley system. A multitude of Etteplan’s offices in Finland and Sweden provide crucial resources and expertise in the development and helps to secure a timely progress of the project.  For Epiroc, the trolley truck project

Interim report January-March 2022

Castellum reports largest increase in earnings in its history· Income for the period January–March 2022 MSEK 2,193 (1,502).  · Income from property management MSEK 1,151 (779), corresponding to SEK 3.40 per share (2.82).  · Change in value on properties MSEK 442 (1,607) and derivatives MSEK 1,366 (19).  · Net income for the period MSEK 3,613 (3,840), corresponding to SEK 10.68 (13.90) per share.  · Long-term net reinstatement value (EPRA NRV) amounted to SEK 259 per share (220), an increase of 18 per cent.  · Investments totalling MSEK 1,195 (688) in existing

Handelsbanken’s interim report for January – March 2022 will be presented Wednesday 27 April

Handelsbanken publishes its interim report for January ­– March 2022, at 06:30 a.m. CET Wednesday, 27 April. The President and Group Chief Executive Officer Carina Åkerström will present the Bank’s interim report together with CFO and Executive Vice President Carl Cederschiöld at 08:30 a.m. CET. The presentation will be broadcast live and available at handelsbanken.com/ir and will be simultaneously interpreted to English. A question and answer session for members of media and analysts will take place immediately following the presentation. To participate, dial in ten minutes before

Nitro Games Oyj: Interim report January – March 2022

The interim period January – March 2022 · Revenue (Jan - Mar): 1 133,3 KEUR (165,9 KEUR). · EBITDA: -946,0 KEUR (-911,9 KEUR). · EBIT: - 1 139,1 KEUR (-1 080,7 KEUR). · Net result: -1 144,4 KEUR (-1 086,2 KEUR). · Earnings per share (EPS) -0,1 (-0,1). · Cash and cash equivalents: 2 436,2 KEUR (31 March 2022).  (Numbers in brackets refer to the corresponding year-on-year period) Significant events during January – March 2022 · Tobias Andersson resigned from the board in January 2022 for personal reasons. · Nitro Games signed a development agreement with

Notice of Extraordinary General Meeting in DexTech Medical AB

Dextech Medical AB's shareholders are welcome to attend the Extraordinary General Meeting which will take place on Wednesday, May 11, 2022 at 10.00 in IVA's conference center, Royal. Academy of Engineering Sciences, Grev Turegatan 16, Stockholm. Admission to the meeting begins at 9.30. Registration and registration Shareholders who wish to participate in the Extraordinary General Meeting must • be entered in the share register kept by Euroclear Sweden AB on Tuesday, May 3, 2022 and • register with the company no later than Friday, May 6, 2022. Registration can be made via e-mail

Stayble Therapeutics has recruited 75% of the patients in the ongoing phase IIb trial

Stayble Therapeutics AB (“Stayble” or “the Company”) announces today that the Company has recruited 75% of all patients with chronic disc-related back pain to the ongoing clinical phase IIb study with STA363. The company has made several efforts to increase the recruitment of patients for the study at the participating clinics in Russia, the Netherlands and Spain. These activities, together with a reduced impact of the Covid-19 pandemic, have resulted in a significant increase in recruitment rates and activity at the clinics involved. The recruitment speed is in line with the set schedule and

Viaplay adds NHL and KSW rights to UK sports streaming offering

· Viaplay to show National Hockey League (NHL), the world’s best ice hockey league, through the 2026-2027 season in UK, extending partnership to 10 European markets · Live events from KSW, Europe’s leading MMA promotion, to be broadly available in UK for first time · Addition of live sports to Viaplay’s UK offering announced in March Viaplay will become home to the National Hockey League (NHL) and KSW mixed martial arts (MMA) in the UK. Up to 1,400 games from the world’s best ice hockey league will be shown on Viaplay every year until 2027, alongside 12 high-impact live events from

Skanska builds theater and museum in Trondheim, Norway for NOK 410M, about SEK 430M

Skanska has signed a contract with Trondheim Postgård DA, owned by Reitan AS, to build a new theatre and museum in Trondheim, Norway. The contact is worth NOK 410M, about SEK 430M, which will be included in the Nordic order bookings for the second quarter 2022.The project is called Nye Hjorten Teater & Posten Modern Museum. Since January 2021, Skanska has been working in close collaboration with the customer, architect, and consultants in the development phase of the project. The project is a combination of rehabilitation and conversion of the old post office building in Trondheim into a

Invitation to presentation of Storytel AB’s Q1 Report 2022

On 5 May 2022 at 8.00 AM CET, Storytel AB will publish its Q1 Report for 2022. Storytel AB will hold a presentation of the report on the same day and invites investors, analysts and media to a webcast at 10.30 AM CET. The presentation will be in English and followed by a Q&A with Storytel’s acting Chief Executive Officer Ingrid Bojner and interim Chief Financial Officer Susanne Ekblom.The Q1 Report for 2022 will be available here  at 8.00 AM CET on 5 May. Information to participants:If you wish to participate,

YIT restates financial information for 2021 reflecting operating model change and the sale of Russian businesses

YIT Corporation Stock exchange release 25 April 2022 at 09:00 a.m.YIT restates financial information for 2021 reflecting operating model change and the sale of Russian businesses As previously communicated, YIT has changed its operating model, and signed an agreement for the sale of its businesses in Russia. As a result, YIT has restated financial information for 2021. The attached tables present the restated consolidated income statement, comprehensive income, and segment financial information as well as certain key ratios on an unaudited basis for all quarters of 2021 and full year

Scandinavian Biogas´ report for the first quarter and invitation to a digital conference on the 28[th] of April, 2022

Scandinavian Biogas will publish the report for the first quarter of 2021 on Thursday the 28[th] of April at approximately 07.30. A conference meeting for investors, analysts and the media will be held at 10.00 the same day. The report will be presented at the conference call by CEO Matti Vikkula and CFO Anna Budzynski. The presentation will be held in English and will begin with a short presentation of the report followed by a question-and-answer session. To participate in the conference call, use this Teamslink 

MSAB´s annual report for 2021 published

The Swedish version of MSAB's annual report 2021 is now available for download on the company’s website www.msab.com. The English version of the annual report is expected to be available on MSAB's website on May 9, 2022.This information is information that MSAB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication of the contact person set out below, at April 25, 2022, 08:00 CEST.

Episealer® presentation at the 20th ESSKA Congress, held on April 27-29 in Paris, France

Episurf Medical (NASDAQ: EPIS B) will attend the 20th ESSKA Congress, held on April 27-29 in Paris, France. At the congress, a scientific presentation, focusing on the company’s Episealer® knee and Episealer® Talus technologies will be held by Prof. Niek van Dijk and Prof. Peter Verdonk. The presentation, entitled “Personalised joint resurfacing – treatment of (osteo-)chondral lesions in the knee and ankle”, will be held on Wednesday April 27 at 13.00. ESSKA is the European Society of Sports Traumatology, Knee Surgery and Arthroscopy. Their goal is to bring together orthopaedic surgeons,

Stora Enso divests its sawmills and forest operations in Russia

STORA ENSO OYJ INVESTOR NEWS 25 April 2022 at 9:00 EESTStora Enso has entered into an agreement to divest its two sawmills in Russia. The Company’s Nebolchi and Impilahti sawmills will be divested to local management. In addition, the divestment includes Stora Enso’s Russian forest operation which through its harvesting supplies wood to the sawmills. Stora Enso’s assessment is that due to the uncertainties in the Russian market, local ownership and operation can provide a more sustainable long-term solution for these business operations and the employees working there. The transaction

There are no items matching the current filter
There are no more items matching the current filter
Back to top